Age-related EBV-associated B-cell lymphoproliferative disorders: Diagnostic approach to a newly recognized clinicopathological entity

Pathology International

Volumn 59, Issue 12, 2009, Pages 835-843

  Shimoyama, Yoshie ^a   Asano, Naoko ^b   Kojima, Masaru ^c   Morishima, Satoko ^d   Yamamoto, Kazuhito ^d   Oyama, Takashi ^e   Kinoshita, Tomohiro ^f   Nakamura, Shigeo ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^f NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; B cell lymphoma; EBV; Hodgkin lymphoma; Immunodeficiency; Senescence

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

B LYMPHOCYTE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GENOTYPE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; LARGE CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED;

EID: 71049116777     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02466.x     Document Type: Review

References (21)

1. Fukayama M, Hino R, Uozaki H. Epstein-Barr virus and gastric carcinoma: Virus-host interactions leading to carcinoma. Cancer Sci 2008 99 : 1726 1733.
2. Takeuchi K, Tanaka-Taya K, Kazuyama Y et al. Prevalence of EBV in Japan: Trends and future prediction. Pathol Int 2006 56 : 112 116.
3. Oyama T, Ichimura K, Suzuki R et al. Senile EBV+ B-cell lymphoproliferative disorders: A clinicopathologic study of 22 patients. Am J Surg Pathol 2003 27 : 16 26.
4. Shimoyama Y, Oyama T, Asano N et al. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: A mini review. J Clin Exp Hematopathol 2006 46 : 1 4.
5. Oyama T, Yamamoto K, Asano N et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients. Clin Cancer Res 2007 13 : 5124 5132.
6. Shimoyama Y, Yamamoto K, Asano N, Oyama T, Kinoshita T, Nakamura S. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: Special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci 2008 99 : 1085 1091.
7. Asano N, Yamamoto K, Tamaru JI et al. Age-related EBV-associated B-cell lymphoproliferative disorders: Comparison with EBV-positive classical Hodgkin lymphoma in elderly patients. Blood 2009 113 : 2629 2636.
8. Nakamura S, Jaffe ES, Swerdlow SH. EBV positive diffuse large B-cell lymphoma of the elderly. In : Swerdlow SH, Campo E, Harris NL et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon : IARS Press, 2008 243 244.
9. Kojima M, Kashimura M, Itoh H et al. Epstein-Barr virus-related reactive lymphoproliferative disorders in middle-aged or elderly patients presenting with atypical features. A clinicopathological study of six cases. Pathol Res Pract 2007 203 : 587 591.
10. Park S, Lee J, Ko YH et al. The impact of the Epstein-Barr Virus status on clinical outcome in diffuse large B cell lymphoma. Blood 2007 110 : 972 978.
11. Kuze T, Nakamura N, Hashimoto Y, Sasaki Y, Abe M. The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: Comparison between EBV(+) and EBV(-) cases in Japanese population. Jpn J Cancer Res 2000 91 : 1233 1240.
12. Yoshino T, Nakamura S, Matsuno Y et al. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Cancer Sci 2006 97 : 163 166.
13. Gibson SE, Hsi ED. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: An uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol 2009 40 : 653 661.
14. Cohen JI, Kimura H, Nakamura S, Ko Y-H, Jaffe ES. Epstein-Barr virus associated lymphoproliferative disease in non-immunocompromised hosts: A status report and summary of an international meeting - September 8-9, 2008. Ann Oncol 2009 20 : 1472 1482.
15. Asano N, Oshiro A, Matsuo K et al. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: A clinicopathologic study. J Clin Oncol 2006 24 : 4626 4633.
16. Rüdiger T, Jaffe ES, Delsol G et al. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol 1998 9 Suppl 5 : S31 8.
17. Jaffe ES, Stein H, Swerdlow SH, Campo E, Pileri SA, Harris NL. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. In : Swerdlow SH, Campo E, Harris NL et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon : IARS Press, 2008 267 268.
18. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol 2004 125 : 267 281.
19. Jarrett RF, Krajewski AS, Angus B et al. The Scotland and Newcastle epidemiological study of Hodgkin's disease: Impact of histopathological review and EBV status on incidence estimates. J Clin Pathol 2003 56 : 811 816.
20. Yasunaga J, Sakai T, Nosaka K et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: Its implications in the immunodeficient state. Blood 2001 97 : 3177 3183.
21. Harada S, Kamata Y, Ishii Y et al. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection. Clin Diagn Lab Immunol 2004 11 : 123 130.